Linda J. Green
Guy's And St Thomas' NHS Trust
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Application of T2 Biomarkers to Support Steroid Stewardship in Severe Asthma - a retrospective cohort study.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 06, 2026
Application of T2 biomarkers to support steroid stewardship in severe asthma-a retrospective cohort study.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 06, 2026
Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 05, 2025
Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 02, 2024
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 24, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
Journal: The European respiratory journal
Published: February 20, 2023
A Feeling for the Human Subject: Margaret Lasker and the Genetic Puzzle of Pentosuria.
Journal: Journal of the history of biology
Published: June 10, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Journal: The European respiratory journal
Published: December 16, 2020
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.
Journal: The journal of allergy and clinical immunology. In practice
Published: December 08, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma.
Journal: Allergy
Published: October 14, 2020
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 13, 2020
Last Updated: 09/26/2026